Clinical Trial Update: Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Anti-D (Rho(D) immune globulin) for thrombocytopenia in adults with hepatitis C with or without HIV infection; the study was terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C
• Thrombocytopenia

Drugs mentioned

• Anti-D (Rho(D) immune globulin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Thrombocytopenia, Hepatitis C | Phase 4 | Status: TERMINATED | Results posted: 2017-05-16